Realcan Pharmaceutical Group Co., Ltd. (002589.SZ)
002589.SZ Stock Price Chart
Explore Realcan Pharmaceutical Group Co., Ltd. interactive price chart. Choose custom timeframes to analyze 002589.SZ price movements and trends.
002589.SZ Company Profile
Discover essential business fundamentals and corporate details for Realcan Pharmaceutical Group Co., Ltd. (002589.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Distribution
IPO Date
10 Jun 2011
Employees
3.24K
Website
https://www.realcan.cnCEO
Xu Han
Description
Realcan Pharmaceutical Group Co., Ltd. sells medicines, medical devices, and medical consumables to medical institution worldwide. It sells drugs, vaccines, and medical devices. The company also provides medical logistics services; third-party logistics services; disinfection and sterilization; and lease, and hospital logistics services for medical institutions. It serves drug distribution, academic services, medical diagnosis, financial technology, traditional Chinese medicine, digital medical care, professional logistics, and comprehensive equipment. The company was formerly known as Realcan Pharmaceutical Co., Ltd. and changed its name to Realcan Pharmaceutical Group Co., Ltd. in December 2018. Realcan Pharmaceutical Group Co., Ltd. was founded in 2004 and is based in Yantai, China.
002589.SZ Financial Timeline
Browse a chronological timeline of Realcan Pharmaceutical Group Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Dividend declared on 8 Jul 2025
A dividend of ¥0.00 per share was announced, adjusted to ¥0.00. The dividend was paid on 8 Jul 2025.
Earnings released on 31 Mar 2025
EPS came in at ¥0.01 , while revenue for the quarter reached ¥1.76B .
Earnings released on 31 Dec 2024
EPS came in at -¥0.01 , while revenue for the quarter reached ¥1.91B .
Earnings released on 29 Sept 2024
EPS came in at ¥0.01 , while revenue for the quarter reached ¥2.02B .
Earnings released on 30 Jun 2024
EPS came in at ¥0.01 , while revenue for the quarter reached ¥2.00B .
Dividend declared on 4 Jun 2024
A dividend of ¥0.01 per share was announced, adjusted to ¥0.01. The dividend was paid on 4 Jun 2024.
Earnings released on 21 May 2024
EPS came in at ¥0.01 , while revenue for the quarter reached ¥2.02B .
Earnings released on 8 Jan 2024
EPS came in at ¥0.00 , while revenue for the quarter reached ¥1.93B .
Earnings released on 30 Sept 2023
EPS came in at -¥0.01 , while revenue for the quarter reached ¥2.03B .
Earnings released on 30 Jun 2023
EPS came in at ¥0.01 , while revenue for the quarter reached ¥2.01B .
Earnings released on 31 Mar 2023
EPS came in at ¥0.02 , while revenue for the quarter reached ¥2.07B .
Earnings released on 1 Jan 2023
EPS came in at -¥1.36 , while revenue for the quarter reached ¥1.41B .
Earnings released on 30 Sept 2022
EPS came in at ¥0.01 , while revenue for the quarter reached ¥3.35B .
Dividend declared on 22 Jul 2022
A dividend of ¥0.01 per share was announced, adjusted to ¥0.01. The dividend was paid on 22 Jul 2022.
Earnings released on 30 Jun 2022
EPS came in at ¥0.03 , while revenue for the quarter reached ¥3.46B .
Earnings released on 29 Apr 2022
EPS came in at -¥0.01 falling short of the estimated ¥0.37 by -101.39%, while revenue for the quarter reached ¥3.42B , missing expectations by -81.41%.
Earnings released on 31 Mar 2022
EPS came in at ¥0.07 , while revenue for the quarter reached ¥4.09B .
Earnings released on 30 Sept 2021
EPS came in at ¥0.06 falling short of the estimated ¥0.18 by -67.66%, while revenue for the quarter reached ¥4.92B , missing expectations by -46.52%.
Earnings released on 30 Jun 2021
EPS came in at ¥0.02 falling short of the estimated ¥0.18 by -88.40%, while revenue for the quarter reached ¥6.95B , missing expectations by -24.57%.
Dividend declared on 23 Jun 2021
A dividend of ¥0.02 per share was announced, adjusted to ¥0.02. The dividend was paid on 23 Jun 2021.
Earnings released on 31 Mar 2021
EPS came in at ¥0.05 falling short of the estimated ¥0.34 by -85.16%, while revenue for the quarter reached ¥5.76B , missing expectations by -65.29%.
Earnings released on 31 Dec 2020
EPS came in at -¥0.03 falling short of the estimated ¥0.18 by -117.34%, while revenue for the quarter reached ¥7.20B , missing expectations by -21.82%.
Earnings released on 31 Oct 2020
EPS came in at ¥0.07 falling short of the estimated ¥0.16 by -57.45%, while revenue for the quarter reached ¥7.32B , missing expectations by -11.87%.
002589.SZ Stock Performance
Access detailed 002589.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.